NYSE: ARMP - Armata Pharmaceuticals, Inc.

Lønnsomhet i seks måneder: -17.58%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Armata Pharmaceuticals, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp.

flere detaljer
for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2011-03-09
ISIN US04216R1023
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.armatapharma.com
Цена ао 4.04
Prisendring per dag: +4.46% (2.02)
Prisendring per uke: +8.21% (1.95)
Prisendring per måned: -8.26% (2.3)
Prisendring over 3 måneder: -10.59% (2.36)
Prisendring over seks måneder: -17.58% (2.56)
Prisendring per år: -34.88% (3.24)
Prisendring over 3 år: -61.71% (5.51)
Prisendring over 5 år: -49.52% (4.18)
Prisendring over 10 år: 0% (2.11)
Prisendring siden begynnelsen av året: -6.22% (2.25)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 18.4 1
P/BV -2.6 0
P/E 0 0
EV/EBITDA -4.76 0
Total: 3.13

Effektivitet

Navn Betydning Karakter
ROA, % -62.79 0
ROE, % 215.33 10
Total: 3.33

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -2.3 10
Total: 7.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 14509.68 10
Lønnsomhet Ebitda, % 119.33 10
Lønnsomhet EPS, % -19.58 0
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
Bank of America Corporation 634451 1.76
Vanguard Group Inc 145078 0.4
Bridgeway Capital Management, Inc. 110382 0.31
Geode Capital Management, LLC 101013 0.28
Edgewood Management Llc 100000 0.28
Renaissance Technologies, LLC 53596 0.15
State Street Corporation 40300 0.11
Qube Research & Technologies Ltd 23563 0.07
Blackrock Inc. 22760 0.06
Northern Trust Corporation 19380 0.05

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Micro-Cap ETF 0.00569 17.09 1.54048



Veileder Stillingstittel Betaling Fødselsår
Dr. Mina Pastagia M.D., MS Chief Medical Officer 463.75k 1975 (50 år)
Dr. Deborah L. Birx M.D. CEO & Director 536.43k 1957 (68 år)
Dr. Pierre Kyme Ph.D. Chief Business Officer N/A
Mr. Peter Hubbard Vice President of Operations N/A
Mr. David House Senior VP of Finance & Principal Financial Officer

Adresse: United States, Marina del Rey. CA, 4503 Glencoe Avenue - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.armatapharma.com